Table 3.

Effect of Active tDCS on Inflammatory Markers.

Measure	Point Estimate	95% Credible Interval	Posterior Probability
IL-10	−.1156	[−.3849, .1569]	80.36%
IL-6	−.2406	[−.7754, .2849]	82.14%
TNF-α	−.0729	[−.2612, .1184]	77.86%
CRP	−.1266	[−.6866, .4358]	67.48%
Cortisol	−.0320	[−.6398, .5717]	54.26%
β-endorphin	−.2693	[−.6600, .1234]	91.42%

Note. Summary of outcome measures from Bayesian generalized linear modeling analyses for each outcome, describing the Bayesian estimate of the effect, the lower and upper 95% credible intervals, and the maximum nonzero posterior probability, with ≥ 75% as the criterion for a group effect shown in bold typeface. CRP = C-reactive protein; IL = interleukin; tDCS = transcranial direct current stimulation; TNF-α = tumor necrosis factor-α.

Outcome measures, with probabilities ≥ 75% noted in bold.